Dose of Reality

DOSE OF REALITY: CONGRESS CAN HOLD BIG PHARMA ACCOUNTABLE FOR GAMING THE SYSTEM TO BLOCK COMPETITION, KEEP DRUG PRICES HIGH

Dec 18, 2024

Lawmakers Should Pass Bipartisan, Market-Based Solutions to Crack Down on Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1 WEIGHT LOSS DRUG PRICES COULD COST MEDICARE $35 BILLION

Oct 10, 2024

CBO Confirms Cost of Blockbuster Obesity Drugs at Current Prices Would Read More

DOSE OF REALITY: BRAND NAME DRUG MAKERS INCREASINGLY UTILIZING ‘USE CODES’ TO GAME PATENT SYSTEM AND BLOCK COMPETITION

Sep 30, 2024

STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further Read More

DOSE OF REALITY: BIG PHARMA’S GLP-1 PRICE-GOUGING UNSUSTAINABLE FOR AMERICAN PATIENTS AND THE U.S. HEALTH SYSTEM

Sep 23, 2024

Brand Name Drug Companies Applying Price-Hiking, Patent Abuse Playbook to Read More

DOSE OF REALITY: BIG PHARMA SETS DRUG PRICES, HIKES DRUG PRICES AND BLOCKS COMPETITION TO KEEP DRUG PRICES HIGH

Sep 10, 2024

Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1, GENE, AND CELL THERAPY PRICES PROJECTED TO INCREASE HEALTH CARE COSTS FOR EMPLOYERS

Aug 26, 2024

Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies” Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM

Jun 25, 2024

Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA STIFLES COMPETITION WITH PRODUCT HOPPING

May 23, 2024

Research Column Explores Case Study in Common Patent Abuse Tactic That Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE BLOCKS COMPETITION IN THE PRESCRIPTION DRUG MARKET, KEEPS DRUG PRICES HIGH

May 21, 2024

Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold Read More

DOSE OF REALITY: STUDY FINDS NEARLY THREE-QUARTERS OF BIG PHARMA’S PATENTS ON TOP-SELLING DRUGS FILED AFTER FDA APPROVAL

May 16, 2024

Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on Read More

DOSE OF REALITY: IQVIA REPORT SHOWS HOW BIG PHARMA’S EGREGIOUS PRICING PRACTICES DRIVE INCREASED PRESCRIPTION DRUG SPENDING

May 10, 2024

Analysis Shows Price Hikes Outpacing Inflation, Rising Launch Prices and Read More